Showing results (2391-2400 of 2,459) with videos related to
Sort By:
Pageof 246
Therapie|December 12, 2017
[Pharmaceutical cognitive doping in students: a chimeric way to get-a-head?]Louise Carton, Nicolas Cabé, Olivier Ménard, et al.Therapie|December 3, 2017
Generic antiretroviral drug use in HIV-infected patients: A cohort study from the French health insurance databaseJoseph Rwagitinywa, Maryse Lapeyre-Mestre, Robert Bourrel, et al.Therapie|May 14, 2018
[Attractiveness of France for international clinical research: 8th survey conducted by Leem (French association for pharmaceutical companies)]Ariane Galaup, Philippe Barthélémy, Brigitte Pouletty-Lefebvre, et al.Therapie|May 21, 2018
Proton pump inhibitors prescriptions in France: Main trends from 2006 to 2016 on French health insurance databaseQuentin Boucherie, Franck Rouby, Diane Frankel, et al.Therapie|March 1, 1997
[Pharmacovigilance of new antidepressants: evaluation of neuro-psychobehavioral disorders]J P Blayac, D Hillaire-Buys, H PeyrièreTherapie|March 1, 1997
[Good practices of publication of clinical cases of pharmacovigilance: comments, Groupe de Travail sur les Bonnes Pratiques de Publication de Cliniques en Pharmacovigilance: commentary]M Auriche, P Bertrand, N Blay, et al.Therapie|March 1, 1997
[Mycophenolate mofetil, a new immunosuppressive agent. Is pharmacokinetic monitoring justified?]J Barré, N Simon, J P TillementTherapie|March 1, 1997
[Apropos of recent antidepressant drugs: some pharmacological comments]J L Montastruc, J M Sénard, M Lapeyre-MestreTherapie|November 5, 2005
The respective roles of controlled clinical trials and cohort monitoring studies in the pre- and postmarketing assessment of drugsMuriel Vray, Bernard Hamelin, Patrice Jaillon, et al.Therapie|November 5, 2005
Methodology for the evaluation and measurement of therapeutic progressDidier Guillemot, Georges France, Pierre Fender, et al.Pageof 246